Key result
Natural statins and other preventive therapies are needed to reduce the burden of stroke, which affects approximately 600,000 persons annually in the United States.
Answers are grounded in this paper and cite their sources.
Highlights the significant public health burden of stroke in the United States and the need for preventive therapies.
The Burden of Stroke I n the United States, Ϸ600 000 persons experience a clinical stroke (first or recurrent) annually.1 Although the case-fatality rate has declined over the past decades, it is still high.The annual death toll is Ϸ150 000, which qualifies stroke as the third leading cause of death, behind coronary heart disease (CHD) and cancer.The clinical sequelae of a stroke are often devastating.Among the more than 3 million stroke survivors, approximately one half have hemiparesis, one third are clinically depressed, one quarter cannot walk, and one sixth are aphasic.2 Stroke is the leading cause of serious disability in the United States. 1 Thus, evidence of promising preventive therapies that can reduce the human and societal costs of stroke is welcome news.
No takes yet. Share an insight, caveat, or question.
Curt D. Furberg (1999) conducted an editorial in Stroke. Natural statins was evaluated. Natural statins and other preventive therapies are needed to reduce the burden of stroke, which affects approximately 600,000 persons annually in the United States.
Synapse has enriched 10 related papers. Consider them for comparative context: